Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2002
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
gptkb:C10AX09
|
| gptkbp:CASNumber |
gptkb:163222-33-1
|
| gptkbp:combines |
gptkb:simvastatin
|
| gptkbp:drugClass |
lipid-lowering agent
|
| gptkbp:eliminationHalfLife |
22 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:ezetimibe
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ezetrol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
cholesterol absorption inhibitor
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
abdominal pain headache myalgia |
| gptkbp:usedFor |
gptkb:familial_hypercholesterolemia
gptkb:sitosterolemia |
| gptkbp:bfsParent |
gptkb:ezetimibe
|
| gptkbp:bfsLayer |
6
|